Internet Archive Scholar

Nintedanib—A Potential New Therapy for Systemic Sclerosis-associated Interstitial Lung Disease

Tejaswini Kulkarni, Audrey Haywood, Anoop M Nambiar, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham AL, USA, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center at San Antonio, TX, USA, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center at San Antonio, TX, USA, South Texas Veterans Health Care System, San Antonio, TX, USA
2020 US Respiratory & Pulmonary Diseases  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (104.6 kB)
https://web.archive.org/web/20210201051902/https://www.touchrespiratory.com/wp-content/uploads/sites/11/2020/11/touchRESP_US_5.1_p28-32.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

doi:10.17925/usprd.2020.5.1.28 fatcat:pl4tr227zzakxedortop6b3g54
Open Access
Citation

Tejaswini Kulkarni, Audrey Haywood, Anoop M Nambiar, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham AL, USA, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center at San Antonio, TX, USA, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center at San Antonio, TX, USA, South Texas Veterans Health Care System, San Antonio, TX, USA. "Nintedanib—A Potential New Therapy for Systemic Sclerosis-associated Interstitial Lung Disease." US Respiratory & Pulmonary Diseases (2020) 28